InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Harris Erik, Vice-Président Exécutif et Directeur Commercial. Insider active across 3 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 17 reports have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €516k. Activity tracked since 6 May 2021. The latest transaction was filed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Harris Erik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
28,895 股0Common StockSEC:0001193125-26-164267:0
11,643 股0Common StockSEC:0001193125-26-089282:0
21,000 股0Common SharesSEC:0000912282-25-001286:0
16,813 股0Common StockSEC:0000950170-25-032773:0
5,967 股0Common StockSEC:0001714899-24-000134:0
19,400 股0Common StockSEC:0000950170-24-026629:0
6,000 股@ US$37.9633.7% 占其流量Common StockSEC:0001209191-23-048491:0
305 股@ US$48.202.1% 占其流量Common StockSEC:0001209191-23-038885:0
4,216 股0Common StockSEC:0001714899-23-000094:0
2,663 股0Common StockSEC:0001209191-23-016039:0
295 股@ US$54.780.0006% mcap3.8% 占其流量Common StockSEC:0001209191-22-038774:0
2,713 股@ US$66.620.0065% mcap39.9% 占其流量Common StockSEC:0001209191-22-015830:0
6,869 股0Common StockSEC:0001714899-22-000024:0
303 股@ US$81.144.1% 占其流量Common StockSEC:0001209191-21-060760:0
375 股@ US$91.535.6% 占其流量Common StockSEC:0001209191-21-045972:0
437 股@ US$94.636.7% 占其流量Common StockSEC:0001209191-21-042812:0
307 股@ US$113.685.6% 占其流量Common StockSEC:0001209191-21-031378:0
17 条申报中的 17 条
About Harris Erik
Harris Erik is Executive Vice President and Chief Commercial Officer. He has 17 filings in total, and the 17 sampled filings cover disposals for EUR 516214 between 2021-05-10 and 2026-04-20, all at Ultragenyx Pharmaceutical Inc.
